Compounded semaglutide
Sold by Neo Soma Healthcare · Injection, vial · every compounded semaglutide record
What you actually pay
Per month
$99
| Medication · Introductory first month | $99 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Introductory first month “Monthly Refills: $99 for your first month, $199/month thereafter” | Per month$99 | Charged today$99 |
| Ongoing monthly refill, 0.25mg-1.00mg/week doses “For Semaglutide, refills are available at a rate of $199 every 4 weeks for doses between 0.25mg per week and 1.00mg per week.” | Per month$199 | Charged today$199 |
| Ongoing monthly refill, 1.50mg-2.40mg/week doses “For doses between 1.50mg per week and 2.40mg per week, the refill rate is $299 every 4 weeks.” | Per month$299 | Charged today$299 |
We earn nothing from this link. Neo Soma Healthcare has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Strive Pharmacy, San Antonio TX |
|---|---|
| Prescriber | Asynchronous review |
| Cancellation | “All sales are final and no refund will be issued.” |
Not yet checked: states, membership and consult fee.
Recorded from neosomahealthcare.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Compounded, not FDA-approved: 'Compounded medications prescribed by Neo Soma providers are not FDA-approved.' Also carries a non-GLP-1 sexual health line (Ignios, Connect troches) which is out of scope for this register. Semaglutide is compounded with cyanocobalamin (B12); tirzepatide with glycine and B12, per the FAQ.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.